Home GlaxoSmithKline plans to seek approval for up to 20 new drugs by 2020, start studies on others
 

Keywords :   


GlaxoSmithKline plans to seek approval for up to 20 new drugs by 2020, start studies on others

2015-11-04 04:50:02| Biotech - Topix.net

GlaxoSmithKline could seek regulatory approval for up to 20 new medicines before 2020 and some could hit the market by then, enabling it to boost revenue rather than just compensate for declining sales of its older drugs. The British drugmaker said it could start late-stage patient testing in the next two years on about 20 new drugs or new uses for existing ones.

Tags: on start others plans

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.06Mining for Pearlizing Agent 
01.06The Power of Zinc Pyrithione
01.06Downward pH Drift
01.06Adding Fragrances to Hot Pours
01.06The Perils of Progress in the Search for New UV Filters
01.06This Interview Formality Jumpstarts Or Kills Your Chances Altogether
01.06Atlantic Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
More »